NVCR - NovoCure Limited (NVCR) CEO Asaf Danziger on Q3 2018 Results - Earnings Call Transcript
NovoCure Limited (NVCR)
Q3 2018 Earnings Conference Call
October 25, 2018 08:00 AM ET
Executives
Ashley Cordova - Senior Vice President, Finance and Investor Relations
Bill Doyle - Executive Chairman
Asaf Danziger - Chief Executive Officer
Wilco Groenhuysen - Chief Financial Officer
Eilon Kirson - Chief Science Officer and Head of Research and Development
Analysts
Vijay Kumar - Evercore ISI
Difei Yang - Mizuho Securities
Larry Biegelsen - Wells Fargo
Matthew - JPMorgan
Presentation
Operator
Good day, ladies and gentlemen. And welcome to the NovoCure Third Quarter 2018 Earnings Call. At this time, all participants